American Flag

Valuation

Financial Asset and Business Valuation

Financial Asset and Business Valuation

NERA economists help clients establish a fair and accurate valuation of a business and/or IPO. Business valuation depends on financial forecasting and analysis -- but that is only the beginning. To make sound forecasts, it is important to understand the dynamics of the marketplace. This is the hallmark of NERA's approach -- one that has been successfully used by business owners and attorneys in litigation, and investment bankers/venture capitalists interested in acquiring a real measure of business value.

Name Title Location Phone Email
Dr. Sumanth Addanki Managing Director White Plains, NY +1 914 448 4060 sumanth.addanki@nera.com
Oscar Arnedillo Managing Director Madrid +34 91 521 0020 oscar.arnedillo@nera.com
Dr. Fabrizio Hernández Managing Director Madrid
Milan 		+34 91 521 00 20
+39 02 30577800 		fabrizio.hernandez@nera.com
Dr. Vinita Juneja Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice 		New York City
London
Toronto 		+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314 		vinita.juneja@nera.com
Dr. Jeff D. Makholm Managing Director Boston +1 617 927 4540 jeff.makholm@nera.com
Dr. Denise Neumann Martin Managing Director New York City +1 212 345 5296 denise.martin@nera.com
Dr. Faten Sabry Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair 		New York City
London 		+1 212 345 3285
+44 20 7659 8618 		faten.sabry@nera.com
Dr. David Tabak Managing Director New York City +1 212 345 2176 david.tabak@nera.com
Bradley A. Heys Director Toronto
New York City 		+1 416 868 7312
+1 212 345 2691 		brad.heys@nera.com
Kurt G. Strunk Director New York City +1 212 345 5035 kurt.strunk@nera.com
Dr. Ling Ling Ang Associate Director New York City
Washington, DC 		+1 212 345 5409
+1 202 466 9259 		lingling.ang@nera.com
Dr. Airat Chanyshev Associate Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Erin B. McHugh Associate Director London
New York City 		+44 20 7659 8736
+1 212 345 2990 		erin.mchugh@nera.com
Bryan Ray Associate Director White Plains, NY +1 914 448 4004 bryan.ray@nera.com
Dr. Michael Baye Affiliated Academic Washington, DC +1 202 466 9298 michael.baye.affiliate@NERA.com
Mark L. Berenblut Affiliated Consultant Toronto
New York City
London 		+1 416 868 7311
+1 917 475 0020
+44 20 7659 8644 		mark.berenblut.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London 		+1 212 345 5407
+44 20 7659 8500 		andrew.carron.affiliate@nera.com
Dr. Alan Cox Affiliated Consultant San Francisco +1 415 291 1000 alan.cox.affiliate@nera.com
Dr. James Jordan Affiliated Consultant Washington, DC +1 202 466 9263 james.jordan.affiliate@nera.com
Todd Morrison Affiliated Consultant Washington, DC +1 202 466 9213 todd.morrison.affiliate@nera.com
Dr. Michael Rosenzweig Affiliated Consultant Washington, DC +1 202 466 9231 michael.rosenzweig.affiliate@nera.com
Title Type Author
Economic and Financial Analyses in Australian Securities Litigation in the Wake of TP... White Paper Dr. David Tabak and Dr. William S. Taylor
Recent Trends in Securities Class Action Litigation: Q1 2020 Update White Paper Janeen McIntosh.and Svetlana Starykh
How Are Different Types of Stocks Weathering COVID-19? Published Article By Dr. Jordan Milev
Trends in Canadian Securities Class Actions: 2019 Update Report Bradley A. Heys, Robert Patton, Jielei Mao
Recent Trends in Securities Class Action Litigation: 2019 Full-Year Review Report Janeen McIntosh and Svetlana Starykh
Fed's Real-Time Payments Idea Presents Risks, Challenges Published Article Ling Ling Ang, with Judy Mok
Fair Value, Transaction Price, and Common Equity Price in Delaware Appraisal Litigati... Published Article William P. Hrycay
Trends in Canadian Securities Class Actions: 2018 Update Report Bradley A. Heys and Robert Patton
Recent Trends in Securities Class Action Litigation: 2018 Full-Year Review Report Stefan Boettrich and Svetlana Starykh
Crypto Market Surveillance Has Arrived Published Article Dr. Jordan Milev, Trevor Wagener, et. al.